Metabolic effects of 20-OH-Ecdysone in ovariectomized rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 119, Issue 3-5, 2010, Pages 121-126

  Seidlova Wuttke, Dana ^a   Ehrhardt, Caroline ^a   Wuttke, Wolfgang ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Ecdysone; Fat tissue; Muscle mass; Serum lipids; Serum thyroid hormones; Uterus

Indexed keywords

ECDYSTERONE; ESTRADIOL; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; FEMALE; LIPID STORAGE; METABOLIC SYNDROME X; METAPHYSIS; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; OBESITY; OVARIECTOMY; QUANTITATIVE STUDY; SPRAGUE DAWLEY RAT; TIBIA; TRIACYLGLYCEROL BLOOD LEVEL; UTERUS; UTERUS WEIGHT;

ANIMALS; BODY COMPOSITION; DOSE-RESPONSE RELATIONSHIP, DRUG; ECDYSTERONE; ESTROGENS; FEMALE; HINDLIMB; INTRA-ABDOMINAL FAT; LEPTIN; LIPIDS; METABOLIC SYNDROME X; OBESITY; ORGAN SIZE; OVARIECTOMY; POSTMENOPAUSE; RATS; RATS, SPRAGUE-DAWLEY; SARCOPENIA; THYROID HORMONES; THYROTROPIN; UTERUS;

ANIMALIA; RATTUS;

EID: 77950300817     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.01.006     Document Type: Article

References (31)

1. Batsis J.A., Nieto-Martinez R.E., Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin. Pharmacol. Ther. 2007, 82(5):509-524.
2. Jiamsripong P., Mookadam M., Honda T., Khandheria B.K., Mookadam F. The metabolic syndrome and cardiovascular disease: part I. Prev. Cardiol. 2008, 11(3):155-161.
3. Redinger R.N. The prevalence and etiology of nongenetic obesity and associated disorders. South Med. J. 2008, 101(4):395-399.
4. Bartels D.W., Davidson M.H., Gong W.C. Type 2 diabetes and cardiovascular disease: reducing the risk. J. Manag. Care Pharm. 2007, 13(2 Suppl. A):S2-S15. quiz S16-17.
5. Poehlman E.T., Toth M.J., Gardner A.W. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann. Intern. Med. 1995, 123(9):673-675.
6. Mayes J.S., Watson G.H. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes. Rev. 2004, 5(4):197-216.
7. Lobo R.A. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008, 60(1):10-18.
8. Villa P., Sagnella F., Perri C., Suriano R., Costantini B., Macri F., Ricciardi L., Lanzone A. Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women. Climacteric 2008, 11(6):498-508.
9. Godsland I.F. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil. Steril. 2001, 75(5):898-915.
10. Hepple R.T. Sarcopenia-a critical perspective. Sci. Aging Knowledge Environ. 2003, 2003(46):pe31.
11. Marzetti E., Leeuwenburgh C. Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp. Gerontol. 2006, 41(12):1234-1238.
12. Wade G.N., Gray J.M. Gonadal effects on food intake and adiposity: a metabolic hypothesis. Physiol. Behav. 1979, 22(3):583-593.
13. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333.
14. Truman J.W. Hormonal control of insect ecdysis: endocrine cascades for coordinating behavior with physiology. Vitam. Horm. 2005, 73:1-30.
15. Dinan L., Lafont R. Effects and applications of arthropod steroid hormones (ecdysteroids) in mammals. J. Endocrinol. 2006, 191(1):1-8.
16. Gorelick-Feldman J., Maclean D., Ilic N., Poulev A., Lila M.A., Cheng D., Raskin I. Phytoecdysteroids increase protein synthesis in skeletal muscle cells. J. Agric. Food Chem. 2008, 56(10):3532-3537.
17. Bathori M., Toth N., Hunyadi A., Marki A., Zador E. Phytoecdysteroids and anabolic-androgenic steroids-structure and effects on humans. Curr. Med. Chem. 2008, 15(1):75-91.
18. Kapur P., Wuttke W., Jarry H., Seidlova-Wuttke D. Beneficial effects of ß-Ecdysone on the joint, epiphyseal cartilage tissue and trabecular bone in ovariectomized rats. Phytomedicine 2010, 10.1016/j.phymed.2010.01.005.
19. Seidlova-Wuttke D., Hesse O., Jarry H., Christoffel V., Spengler B., Becker T., Wuttke W. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. Eur. J. Endocrinol. 2003, 149(4):351-362.
20. Rachon D., Vortherms T., Seidlova-Wuttke D., Wuttke W. Effects of black cohosh extract on body weight gain, intra-abdominal fat accumulation, plasma lipids and glucose tolerance in ovariectomized Sprague-Dawley rats. Maturitas 2008, 60(3-4):209-215.
21. Seidlova-Wuttke D., Jarry H., Becker T., Christoffel V., Wuttke W. Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas 2003, 44(Suppl. 1):S39-50.
22. Seidlova-Wuttke D., Jarry H., Jager Y., Wuttke W. Bone development in female rats maintained with soy-free or soy-containing food as determined by Cooperation tomography and serum bone markers. J. Bone Miner. Metab. 2008, 26(4):321-327.
23. Seidlova-Wuttke D., Prelle K., Fritzemeier K.H., Wuttke W. Effects of estrogen receptor alpha- and beta-selective substances in the metaphysis of the tibia and on serum parameters of bone and fat tissue metabolism of ovariectomized rats. Bone 2008, 43(5):849-855.
24. Owens J.W., Ashby J. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Crit. Rev. Toxicol. 2002, 32(6):445-520.
25. Owens W., Koeter H.B. The OECD program to validate the rat uterotrophic bioassay: an overview. Environ. Health Perspect. 2003, 111(12):1527-1529.
26. Schmutzler C., Hamann I., Hofmann P.J., Kovacs G., Stemmler L., Mentrup B., Schomburg L., Ambrugger P., Gruters A., Seidlova-Wuttke D., Jarry H., Wuttke W., Kohrle J. Endocrine active compounds affect thyrotropin and thyroid hormone levels in serum as well as endpoints of thyroid hormone action in liver, heart and kidney. Toxicology 2004, 205(1-2):95-102.
27. Hallgren S., Darnerud P.O. Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects. Toxicology 2002, 177(2-3):227-243.
28. Kim S., Shevde N.K., Pike J.W. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res. 2005, 20(2):305-317.
29. Jurutka P.W., Bartik L., Whitfield G.K., Mathern D.R., Barthel T.K., Gurevich M., Hsieh J.C., Kaczmarska M., Haussler C.A., Haussler M.R. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J. Bone Miner. Res. 2007, 22(Suppl. 2):V2-V10.
30. Krasovskii G.N. Extrapolation of experimental data from animals to man. Environ. Health Perspect. 1976, 13:51-58.
31. Davidson I.W., Parker J.C., Beliles R.P. Biological basis for extrapolation across mammalian species. Regul. Toxicol. Pharmacol. 1986, 6(3):211-237.